Zusammenfassung
Bei unserer Patientin traten im Zeitraum von sieben Jahren zweimalig rezidivierend
Granulosazelltumoren auf, die zunächst jeweils operativ behandelt wurden. Histologisch
zeigten der initiale Befund sowie das erste Rezidiv mit einem Ki67-Index von weniger
als 2 % aller Tumorzellen eine niedrige Proliferationsrate, während das zweite Rezidiv
eine deutlich erhöhte Mitose- und Proliferationsrate aufwies. Im Anschluss an die
operative Behandlung führten wir hier eine Chemotherapie mit Carboplatin, Epirubicin
und Cyclophosphamid durch. Zur Verlaufsbeobachtung wurde das gonadale Peptid Inhibin
eingesetzt.
Abstract
Within seven years our patient developed a granulosa cell tumor of the ovary which
initially was treated surgically. Histologically, the initial finding as well as the
first recurrence showed a low proliferation rate (Ki67 < 2 % of all tumor cells) whereas
an increase of the mitotic and proliferation rate was observed (Ki67 > 30 %) in the
second recurrence. After surgical treatment of this second recurrence we started a
chemotherapy with carboplatine, epirubicine and cyclophosphamide. For monitoring treatment
and detecting recurrence we used inhibin as tumor marker.
Schlüsselwörter
Granulosazelltumor - Rezidiv - Proliferationsrate - Prognose
Key words
Granulosa cell tumor - recurrence - proliferation rate - prognosis
Literatur
1
Segal R, De Petrillo A D, Thomas G.
Clinical review of adult granulosa cell tumors of the ovary.
Gynecol Oncol.
1995;
56
338-344
2
Malmström H, Hogberg T, Risberg B, Simonsen E.
Granulosa cell tumors of the ovary: prognostic factors and outcome.
Gynecol Oncol.
1994;
52
50-55
3
Gee D C, Russel P.
The pathological assessment of ovarian neoplasms. IV: The sex cord stromal tumors.
Pathology.
1981;
13
235-255
4
Lal A, Bourtsos E P, Nayar R. et al .
Cytologic features of granulosa cell tumors in fluids and fine needle aspiration specimens.
Acta Cytol.
2004;
48
315-320
5
Benjamin E, Law S, Bobrow L G.
Intermediate filaments cytokeratin and vimentin in ovarian sex cord-stromal tumours
with correlative studies in adult and fetal ovaries.
J Pathol.
1987;
152
253-263
6
Gurusinghe C J, Healy D L, Jobling T. et al .
Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue.
Gynecol Oncol.
1995;
57
27-32
7
Wolf J K, Mullen J, Eifel P J, Burke T W, Levenback C, Gershenson D M.
Radiation treatment of advanced or recurrent granusosa cell tumor of the ovary.
Gynecol Oncol.
1999;
73
35-41
8
Sehouli J, Drescher F, Mustea A, Nehmzow M, Friedmann W, Kühn W, Elling D, Klare P,
Lichtenegger W.
Chemotherapy for granulosa cell tumors of the ovary: a review of 25 patients with
long-term follow-up.
Geburtsh Frauenheilk.
2003;
63
529-537
9
Martikainem H, Penttinem J, Huhtaniemi I, Kauppila A.
Gonadotropin-releasing hormone agonist analog therapy effective in ovarian granulosa
cell malignancy.
Gynecol Oncol.
1989;
35
406
10
Cooke I E, O'Brien M, Charnock F M, Groome N P, Ganesan T S.
Inhibin as a marker for ovarian cancer.
Brit J Cancer.
1995;
71
1046-1050
11
Hines J F, Mahmoud A K.
Recurrent granulosa cell tumor of the ovary 37 years after inital diagnosis: a case
report and review of the literature.
Gynecol Oncol.
1995;
60
484-488
12
Sehouli J, Drescher F, Mustea A, Elling D, Friedmann W, Kuhn W, Nehmzow M, Opri F,
Klare P, Dietel M, Lichtenegger W.
Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients.
Geburtsh Frauenheilk.
2004;
64
1223-1229
13
Osmanagaoglu M A, Kadioglu S, Osmanagaoglu S, Bozkaya H.
The relationship of p 53 accumulation and DNA ploidy and conventional clinicopathological
prognostic variables in patients with ovarian carcinoma.
Geburtsh Frauenheilk.
2005;
65
778-785
14
Costa M J, Walls J, Ames P, Roth L M.
Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB‐1) and p 53 immunohistochemistry
demonstrates a possible molecular basis for the poor histopathologic prediction of
clinical behaviour.
Hum Pathol.
1996;
27
274-281
S. Engert
Universitätsfrauenklinik
Josef-Schneider-Straße 4
97080 Würzburg
Email: engert_s1@klinik.uni-wuerzburg.de